Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus
- PMID: 8152488
- DOI: 10.1038/368756a0
Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus
Abstract
The 37-amino-acid polypeptide amylin is the principal constituent of the amyloid deposits that form in the islets of Langerhans in patients with type-2 diabetes mellitus, but its role in the pathogenesis of this disease is unresolved. In view of the fact that the beta-amyloid protein that forms fibrils in Alzheimer's disease is toxic to neurons, we have investigated whether amylin fibrils could be toxic to pancreatic islet cells. We show here that human amylin is toxic to insulin-producing beta-cells of the adult pancreas of rats and humans. This toxicity is mediated by the fibrillar form of the amylin peptide and requires direct contact of the fibrils with the cell surface. The mechanism of cell death involves RNA and protein synthesis and is characterized by plasma membrane blebbing, chromatin condensation and DNA fragmentation, indicating that amylin induces islet cell apoptosis. These findings indicate that amylin fibril formation in the pancreas may cause islet cell dysfunction and death in type-2 diabetes mellitus.
Similar articles
-
Beta-amyloid peptides 1-40betaA and 25-35betaA suppress human amylin-mediated death of RINm5F islet beta-cells with distinct actions on fibril formation.Cell Biol Int. 2008 Apr;32(4):447-55. doi: 10.1016/j.cellbi.2007.12.016. Epub 2008 Jan 11. Cell Biol Int. 2008. PMID: 18291688
-
Biological action of pancreatic amylin: relationship with glucose metabolism, diabetes, obesity and calcium metabolism.Neth J Med. 1992 Aug;41(1-2):82-90. Neth J Med. 1992. PMID: 1407245 Review.
-
The aggregation potential of human amylin determines its cytotoxicity towards islet beta-cells.FEBS J. 2006 Aug;273(15):3614-24. doi: 10.1111/j.1742-4658.2006.05367.x. FEBS J. 2006. PMID: 16884500
-
Human but not rat amylin shares neurotoxic properties with Abeta42 in long-term hippocampal and cortical cultures.FEBS Lett. 2008 Jun 25;582(15):2188-94. doi: 10.1016/j.febslet.2008.05.006. Epub 2008 May 16. FEBS Lett. 2008. PMID: 18486611
-
"A" is for amylin and amyloid in type 2 diabetes mellitus.JOP. 2001 Jul;2(4):124-39. JOP. 2001. PMID: 11875249 Review.
Cited by
-
Helix Dipole and Membrane Electrostatics Delineate Conformational Transitions in the Self-Assembly of Amyloidogenic Peptides.Langmuir. 2020 Jul 28;36(29):8389-8397. doi: 10.1021/acs.langmuir.0c00723. Epub 2020 Jul 15. Langmuir. 2020. PMID: 32628488 Free PMC article.
-
Suppression by polycyclic compounds of the conversion of human amylin into insoluble amyloid.Biochem J. 2003 Sep 15;374(Pt 3):779-84. doi: 10.1042/BJ20030422. Biochem J. 2003. PMID: 12812521 Free PMC article.
-
The small molecule inhibitor anle145c thermodynamically traps human islet amyloid peptide in the form of non-cytotoxic oligomers.Sci Rep. 2019 Dec 13;9(1):19023. doi: 10.1038/s41598-019-54919-z. Sci Rep. 2019. PMID: 31836748 Free PMC article.
-
Islet amyloid polypeptide in pancreatic islets from type 1 diabetic subjects.Islets. 2011 Jul-Aug;3(4):166-74. doi: 10.4161/isl.3.4.15875. Epub 2011 Jul 1. Islets. 2011. PMID: 21633185 Free PMC article.
-
Interaction between amyloid beta peptide and an aggregation blocker peptide mimicking islet amyloid polypeptide.PLoS One. 2011;6(5):e20289. doi: 10.1371/journal.pone.0020289. Epub 2011 May 25. PLoS One. 2011. PMID: 21633500 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
